Vaxart, Inc. Accounts Payable
Vaxart, Inc. (VXRT) had Accounts Payable of $17.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableCurrentAndNoncurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable $17.00M.
- 2026-03-31: Accounts Payable $24.20M.
- 2025-12-31: Accounts Payable $21.50M.
- 2025-09-30: Accounts Payable $53.10M.
| Period end | Accounts Payable |
|---|---|
| 2026-06-30 | $17.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $24.20M S-1 · filed 2026-05-08 |
| 2025-12-31 | $21.50M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $53.10M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.60M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $16.60M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $7.00M S-1 · filed 2026-05-08 |
| 2023-12-31 | $1.60M 10-K · filed 2025-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |